{"id":"W4414508430","doi":"10.1001/jamaoncol.2025.3700","title":"Ribociclib Plus Endocrine Therapy in Hormone Receptor–Positive/ <i>ERBB2</i> -Negative Early Breast Cancer","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency; College of Medicine, Seoul National University; University of California, Los Angeles; Instituto de Investigación Sanitaria Gregorio Marañón; Peter MacCallum Cancer Centre; Chinese Academy of Medical Sciences; Seoul National University Hospital; Universidad Complutense de Madrid; Seoul National University; Peking Union Medical College; University of Washington; University of Texas MD Anderson Cancer Center; Novartis Pharmaceuticals Corporation; Cancer Research Institute","keywords":"Endocrine system; Breast cancer; Hormone receptor; Cancer; Hormone therapy; Hormone","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000199868,0.0003202938,0.0008189403,0.00029329,0.00008545318,0.00002006184,0.0002055576,0.0002503652,0.0004570837],"category_scores_gemma":[0.00007143111,0.0002831521,0.0001254738,0.0007889312,0.0003455741,0.0002511059,0.0000976064,0.0007155823,0.00005387746],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002114128,"about_ca_system_score_gemma":0.0009458327,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002524134,"about_ca_topic_score_gemma":0.0005450365,"domain_scores_codex":[0.9979354,0.0002179803,0.0004599807,0.000549645,0.0002238832,0.0006131628],"domain_scores_gemma":[0.9986334,0.0004085742,0.0001717643,0.0003534663,0.0002927315,0.0001400726],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.02244528,0.0007477313,0.03237574,0.00004866657,0.0005733005,0.0003187985,0.003250658,0.00005702554,0.07367278,0.001471026,0.005738205,0.8593008],"study_design_scores_gemma":[0.03306442,0.001752863,0.7713318,0.0003620497,0.00007411282,0.0002328176,0.0007886993,0.00005870125,0.01640656,0.001711065,0.1738214,0.0003955858],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9100415,0.006541041,0.0003411612,0.06434149,0.0007827764,0.001355412,0.0002138256,0.0001789745,0.01620389],"genre_scores_gemma":[0.9768889,0.003081866,0.001807837,0.01277196,0.0005892866,0.000608802,0.00003107935,0.00005498089,0.00416531],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8589052,"threshold_uncertainty_score":0.9999621,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01289298974343171,"score_gpt":0.331732048033634,"score_spread":0.3188390582902023,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}